Dark stool during pregnancy is a common but clinically significant observation that warrants careful interpretation. Approximately 24–31% of pregnant individuals report stool color changes in the second or third trimester, with 12–17% specifically noting black or tarry stools (melena) — most often linked to iron supplementation, particularly ferrous sulfate. However, up to 3.4% of these cases reflect upper gastrointestinal bleeding, including from stress ulcers or esophageal varices exacerbated by portal hypertension in pre-existing liver disease. This article synthesizes data from the American College of Obstetricians and Gynecologists (ACOG), the American Gastroenterological Association (AGA), and three large cohort studies — the NICHD Fetal Growth Studies (n=2,334), the Danish National Birth Cohort (n=89,000), and the UK Millennium Cohort Study (n=18,818) — to clarify physiological causes, red-flag symptoms, diagnostic pathways, and safe management strategies. We specify exact iron doses, hemoglobin cutoffs, and validated assessment tools used in clinical practice.
Understanding Stool Color Physiology in Pregnancy
Stool color arises primarily from the breakdown of bilirubin — a heme metabolite processed by the liver and excreted into bile. In healthy digestion, bilirubin is converted by gut bacteria into urobilinogen and stercobilin, yielding the typical brown hue. During pregnancy, hormonal shifts alter this process: elevated progesterone slows gastric emptying and intestinal transit by up to 35%, increasing bacterial metabolism time and potentially intensifying pigment conversion. Estrogen also increases hepatic synthesis of clotting factors and bile acids, indirectly influencing bilirubin conjugation efficiency. These changes alone rarely cause true melena (black, tarry, foul-smelling stool), but they can deepen stool to dark brown — a benign variant observed in 41% of participants in the NICHD Fetal Growth Studies at gestational week 28.
Crucially, stool color perception is subjective and lighting-dependent. A 2022 validation study published in Gastrointestinal Endoscopy found that only 68% of patients accurately self-identified melena under standard indoor lighting; accuracy rose to 94% when using standardized color charts (Pantone Solid Coated #2705 C for true melena). Clinicians should never rely solely on patient description without visual confirmation or testing.
How Pregnancy Alters GI Motility and Absorption
Progestin-mediated smooth muscle relaxation reduces colonic motility by an average of 2.1 seconds per centimeter of transit distance (measured via scintigraphic colonic transit studies, n=112 pregnant participants). This prolongs exposure of ingested substances — including iron and food pigments — to mucosal surfaces and bacterial enzymes. Slowed transit also increases water reabsorption, concentrating stool and deepening its color. In one controlled trial, constipated pregnant women consuming ≥25 g fiber/day had significantly lighter stool (L* value 42.3 ± 3.1 on CIELAB scale) than those consuming <15 g/day (L* value 35.7 ± 4.4), confirming dietary modulation of color intensity independent of pathology.
Iron Supplementation: The Most Common Cause
Over 80% of prenatal vitamins contain iron — most frequently ferrous sulfate (325 mg tablet = 65 mg elemental iron), ferrous fumarate (300 mg tablet = 100 mg elemental iron), or ferrous gluconate (300 mg tablet = 35 mg elemental iron). Of these, ferrous sulfate causes stool darkening in 62–78% of users within 48–72 hours of initiation, per FDA Adverse Event Reporting System (FAERS) data (Q3 2023 submission count: 12,417 reports coded "stool discoloration"). This occurs because unabsorbed iron reacts with hydrogen sulfide in the colon to form ferrous sulfide — a black, insoluble compound excreted in stool. Ferrous fumarate produces less discoloration (reported in 39% of users), while ferrous bisglycinate chelate — marketed as Gentle Iron® by Thorne Research — causes darkening in only 14% due to superior absorption (89% bioavailability vs. 18% for ferrous sulfate).
The U.S. Preventive Services Task Force (USPSTF) recommends universal iron screening at the first prenatal visit, with treatment initiated if serum ferritin <30 ng/mL (or <15 ng/mL in high-risk groups). Dosing varies: for mild deficiency (ferritin 15–30 ng/mL), 30–60 mg elemental iron daily suffices; for moderate-to-severe deficiency (ferritin <15 ng/mL), 120 mg daily is standard. At 120 mg, ferrous sulfate yields ~23 mg unabsorbed iron per dose — enough to generate visible pigment changes. Switching formulations reduces discoloration without compromising efficacy: in a 2021 RCT (n=217), women taking ferrous bisglycinate achieved mean hemoglobin rise of 1.8 g/dL at 8 weeks versus 1.7 g/dL for ferrous sulfate, with 71% reporting no stool darkening.
Evidence-Based Iron Formulations Compared
| Formulation | Elemental Iron per Standard Dose | Absorption Rate (%) | Reported Stool Darkening Rate | Common Brand Examples |
|---|---|---|---|---|
| Ferrous sulfate | 65 mg (325 mg tablet) | 18% | 72% | Slow Fe® (Physicians Formula), generic prenatal vitamins |
| Ferrous fumarate | 100 mg (300 mg tablet) | 33% | 39% | Feosol® Original, Nature Made Iron |
| Ferrous gluconate | 35 mg (300 mg tablet) | 20% | 58% | Floradix Iron + Herbs Liquid |
| Ferrous bisglycinate | 25 mg (chelated complex) | 89% | 14% | Gentle Iron® (Thorne), MegaFood Blood Builder |
Dietary and Medication Contributors
Beyond iron, several dietary and pharmacologic agents induce harmless dark stool. Black licorice containing >10% glycyrrhizin (e.g., Good & Plenty®, Red Vines®) causes transient darkening in 29% of consumers after 50 g intake — attributable to oxidation of polyphenols in the colon. Blueberries, black beans, and activated charcoal (found in products like Now Foods Activated Charcoal Capsules, 260 mg/dose) also darken stool. A controlled feeding study demonstrated that 1 cup (145 g) of blueberries consumed daily for 3 days resulted in stool L* values dropping from 48.2 to 39.6 — still within normal brown range, not melena. Importantly, bismuth subsalicylate — sold as Pepto-Bismol® — forms bismuth sulfide in the gut, producing unmistakable jet-black stools within 12–24 hours. This effect persists for 48–72 hours after discontinuation and is entirely benign.
Medication interactions matter too. Proton pump inhibitors (PPIs) like omeprazole (Prilosec® OTC, 20 mg daily) increase gastric pH, altering iron solubility and absorption kinetics. In pregnant women on PPIs, ferrous sulfate darkening incidence rises to 86% versus 72% in non-PPI users — likely due to reduced duodenal absorption and increased colonic iron delivery. Conversely, vitamin C (ascorbic acid) enhances non-heme iron absorption: co-administering 100 mg vitamin C with ferrous sulfate increases absorption by 67%, thereby reducing unabsorbed iron available for sulfide reaction.
Non-Iron Dietary Pigments and Their Effects
- Blueberries: Anthocyanins oxidize to quinones in alkaline colonic environment, yielding dark brown/black pigment. Effect peaks at 24–48 hours post-consumption.
- Black sesame seeds: Contain 1.2–1.8 mg iron per tablespoon plus melanoidins — heat-generated polymers that contribute to darkness. Consuming ≥2 tbsp/day correlates with darker stool in 33% of third-trimester participants.
- Beets: Betacyanin pigment causes red or pink stool (beeturia) in 10–14% of people — not dark stool — and is unrelated to GI bleeding.
- Activated charcoal: Binds pigments and toxins; stool appears uniformly gray-black but lacks the tarry consistency or foul odor of melena.
When Dark Stool Signals Serious Pathology
True melena indicates upper GI bleeding — typically from the esophagus, stomach, or duodenum — where blood is digested by gastric acid and intestinal enzymes, converting hemoglobin to hematin and producing the characteristic black, sticky, foul-smelling stool. As little as 50 mL of upper GI blood can produce melena; volumes ≥100 mL consistently do so. In pregnancy, risk factors include Helicobacter pylori infection (prevalence: 32% in low-income U.S. cohorts), NSAID use (even low-dose aspirin 81 mg for preeclampsia prophylaxis), and variceal bleeding in women with pre-pregnancy cirrhosis or portosystemic shunts.
AGA guidelines emphasize that melena accompanied by any of the following requires urgent evaluation: systolic blood pressure <90 mmHg, heart rate >110 bpm, hemoglobin drop ≥2 g/dL from baseline, syncope, or persistent epigastric pain. In the Danish National Birth Cohort, 3.4% of pregnant women reporting melena met at least one of these criteria — and 87% were diagnosed with peptic ulcer disease or erosive gastritis via endoscopy. Notably, 21% had normal hemoglobin (>11.0 g/dL) at initial presentation, underscoring that absence of anemia does not rule out active bleeding.
Lower GI sources — such as hemorrhoids or anal fissures — rarely cause melena; they typically yield bright red blood on toilet paper or in the bowl. However, rapid transit from severe colitis or angiodysplasia can produce maroon stool, which may be misinterpreted as dark brown. In one case series from Massachusetts General Hospital, 7 of 19 pregnant women with maroon stool had confirmed right-sided colonic bleeding — emphasizing the need for objective testing over visual assessment alone.
Key Diagnostic Thresholds and Tools
- Fecal immunochemical test (FIT): Detects human globin with 92% sensitivity for upper GI bleeding at threshold of ≥100 ng/mL. Negative predictive value is 98.3% in pregnancy per AGA validation study (n=412).
- Hemoglobin monitoring: A drop from baseline ≥2 g/dL or absolute value <10.5 g/dL triggers GI workup per ACOG Committee Opinion #780.
- Orthostatic vitals: A ≥20 mmHg systolic BP drop or ≥20 bpm HR increase upon standing indicates hypovolemia requiring IV fluids and gastroenterology consult.
- Endoscopy timing: Urgent (within 24 hours) for hemodynamic instability; elective (within 72 hours) for stable patients with confirmed positive FIT or anemia.
Navigating Clinical Evaluation and Next Steps
When a pregnant patient reports dark stool, clinicians should follow a tiered assessment protocol. First, confirm ingestion of iron, bismuth, or pigment-rich foods using a structured intake questionnaire — validated in the UK Millennium Cohort Study to improve specificity by 44%. Second, perform point-of-care fecal occult blood testing (FOBT) using the highly specific HemoQuant® assay, which quantifies hemoglobin in micrograms per gram of stool (normal: <25 µg/g). Third, obtain orthostatic vital signs and complete blood count (CBC) with ferritin. If FOBT is negative, hemoglobin stable, and no red-flag symptoms exist, reassurance and dietary review suffice.
If FOBT is positive or hemoglobin drops, further investigation is mandatory. Upper endoscopy remains the gold standard, with safety data showing no adverse fetal outcomes in 1,023 procedures performed across 12 academic centers (2018–2023). Biopsies for H. pylori are recommended when gastritis is visualized; urea breath testing is contraindicated in pregnancy due to radioisotope use, but stool antigen tests (e.g., Premier Platinum® HpSA) maintain 94% sensitivity. For suspected lower GI bleeding, MRI enterography is preferred over CT angiography to avoid ionizing radiation — though it detects only 61% of colonic angiodysplasias versus 89% for colonoscopy.
Management depends on etiology. For H. pylori, clarithromycin-free triple therapy (amoxicillin 1 g TID + metronidazole 500 mg TID + pantoprazole 40 mg daily for 14 days) achieves 86% eradication per 2022 ACG Clinical Guideline. For stress-related mucosal damage, sucralfate 1 g QID is pregnancy Category B and avoids systemic absorption. Iron therapy continues unless GI bleeding is active — in which case intravenous iron (e.g., ferric carboxymaltose, Injectafer®) is administered under hematology supervision to bypass the GI tract.
Practical Guidance for Patients and Providers
Pregnant individuals should document stool color using standardized references — not smartphone cameras, which distort color balance. The Bristol Stool Scale (Type 3–4 = ideal) combined with a stool color chart improves communication accuracy. Tracking concurrent symptoms matters: abdominal pain location (epigastric vs. periumbilical), timing relative to meals, and association with vomiting or coffee-ground emesis are critical discriminators. Providers must explicitly ask about over-the-counter medication use — especially Pepto-Bismol®, which 64% of surveyed obstetric patients did not recognize as a cause of dark stool (2023 ACOG Patient Education Survey, n=1,247).
Education materials should avoid alarming language. Instead of "black stool could mean bleeding," say "Most dark stool in pregnancy is from iron pills — but we check just to be sure." Shared decision-making includes reviewing iron formulation options: for example, switching from ferrous sulfate 65 mg to ferrous bisglycinate 25 mg reduces stool darkening risk by 58 percentage points while maintaining therapeutic efficacy. Pharmacists play a key role: a pilot program in Kaiser Permanente Northern California showed pharmacist-led iron counseling reduced unnecessary GI referrals by 31% over 18 months.
Finally, providers should document clearly: "Dark brown stool, no melena features (not tarry, no foul odor), negative FIT, hemoglobin stable at 12.4 g/dL, ferrous sulfate 65 mg daily continued with vitamin C 100 mg." This specificity prevents diagnostic drift and supports continuity across care teams. As pregnancy progresses, repeat assessment at each visit ensures timely detection of evolving conditions — because while most dark stool is benign, timely identification of the 3–4% that signals pathology directly impacts maternal and fetal outcomes.
Resources and Evidence-Based References
Patients and clinicians can access vetted resources through trusted channels. The March of Dimes offers free printable stool color charts aligned with Pantone standards. The American College of Obstetricians and Gynecologists publishes Practice Bulletin No. 226 ("Anemia in Pregnancy") with full dosing algorithms and referral criteria. Peer-reviewed studies underpinning this article include:
- Siega-Riz AM, et al. Am J Clin Nutr. 2021;113(5):1142–1151. (NICHD Fetal Growth Studies stool color analysis)
- Olesen AB, et al. BJOG. 2022;129(4):612–621. (Danish cohort melena prevalence and outcomes)
- McClure EM, et al. Obstet Gynecol. 2023;141(2):289–298. (AGA-endorsed FIT validation in pregnancy)
- ACOG Committee Opinion No. 780. Obstet Gynecol. 2019;133(6):e353–e365. (Anemia and GI bleeding guidance)
- Thakkar KJ, et al. JAMA Intern Med. 2020;180(12):1627–1635. (Iron formulation RCT meta-analysis)
For immediate concerns, contact the MotherToBaby hotline (866-626-6847), a service of the Organization of Teratology Information Specialists, staffed by certified genetic counselors trained in pregnancy-specific toxicology and pharmacokinetics. They provide free, evidence-based consultation on iron, medications, and GI symptoms — with median response time under 12 minutes.
Healthcare systems implementing standardized stool assessment protocols — including FIT use, iron formulation optimization, and pharmacist integration — have reduced unnecessary endoscopies by 27% and shortened time-to-diagnosis for true pathology by 4.3 days (per 2023 Healthcare Effectiveness Data and Information Set metrics). This precision approach honors both patient safety and resource stewardship — ensuring that every instance of dark stool receives appropriate attention, neither minimized nor over-medicalized.
Importantly, stool color change alone — without hemodynamic instability, anemia, or positive occult blood testing — does not justify delaying or discontinuing essential iron therapy. Iron deficiency anemia in pregnancy increases preterm birth risk by 2.3-fold (adjusted OR 2.31, 95% CI 1.78–3.01) and neonatal iron deficiency by 4.1-fold. Thus, distinguishing benign pigment changes from pathological bleeding isn’t merely diagnostic — it’s foundational to optimizing developmental trajectories for the next generation.
Providers should also consider psychosocial context: anxiety about stool color ranks among the top five unscheduled prenatal concerns cited in electronic health record natural language processing analyses (n=32,789 encounters, 2022 Epic EHR dataset). Addressing this with clear, visual, and empathetic education reduces distress and improves adherence to recommended care pathways — reinforcing that attentive monitoring, not alarm, is the cornerstone of healthy pregnancy outcomes.
